Items where authors include "Jørgensen, N.R."

Article

Bhattoa, H.P. orcid.org/0000-0002-4909-0065, Vasikaran, S. orcid.org/0000-0002-0831-3031, Trifonidi, I. orcid.org/0000-0002-3999-8459 et al. (34 more authors) (2025) Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporosis International, 36 (4). pp. 579-608. ISSN 0937-941X

Lombardi, G. orcid.org/0000-0002-8365-985X, Jørgensen, N.R. orcid.org/0000-0001-9624-5210, Harvey, N.C. orcid.org/0000-0002-8194-2512 et al. (14 more authors) (2025) Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism. Clinical Chemistry and Laboratory Medicine (CCLM), 63 (4). pp. 704-711. ISSN 1434-6621

Hansen, M.S. orcid.org/0000-0001-8269-8542, Wölfel, E.M., Jeromdesella, S. et al. (6 more authors) (2024) Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. eClinicalMedicine, 72. 102624. ISSN 2589-5370

Agrawal, A., Ellegaard, M., Haanes, K.A. et al. (5 more authors) (2022) Absence of P2Y2 receptor does not prevent bone destruction in a murine model of muscle paralysis-induced bone loss. Frontiers in Endocrinology, 13. 850525. ISSN 1664-2392

Cavalier, E., Eastell, R. orcid.org/0000-0002-0323-3366, Jørgensen, N.R. et al. (7 more authors) (2021) A multicenter study to evaluate harmonization of assays for C-terminal telopeptides of type I collagen (ß-CTX): A report from the IFCC-IOF Committee for Bone Metabolism (C-BM). Calcified Tissue International, 108 (6). pp. 785-797. ISSN 0171-967X

Agrawal, A., Kruse, L.S., Vangsted, A.J. et al. (2 more authors) (2020) Human P2X7 receptor causes cycle arrest in RPMI-8226 myeloma cells to alter the interaction with osteoblasts and osteoclasts. Cells, 9 (11). 2341.

Wang, N. orcid.org/0000-0002-2663-7515, Agrawal, A. orcid.org/0000-0003-1055-9142, Jørgensen, N.R. et al. (1 more author) (2018) P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis. Scientific Reports, 8 (1). 3507. ISSN 2045-2322